This inventor holds 2 USPTO granted patents. Top assignees: Basf Aktiengesellschaft, Egis Gyogyszergyar. Active years: 1988-1990.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1988-1990
Title: Katalin Budai Nee Simonyi: A Trailblazer in Pharmaceutical Innovations
Introduction
Katalin Budai Nee Simonyi, based in Budapest, Hungary, is an accomplished inventor recognized for her significant contributions to the field of pharmaceuticals. With two patents to her name, her work focuses on innovative compounds that hold promise for central nervous system applications.
Latest Patents
Katalin's latest patents reveal her expertise in developing new pharmaceutical compositions. Her first patent, titled "Quinoline thioethers - The new compounds of the general Formula I," presents a series of novel compounds involving various alkyl and cycloalkyl groups. These compounds are anticipated to have valuable applications in medical chemistry. The second patent, "Pharmaceutical compositions of 2-methyl-thiazolo[4,5-c]quinoline," describes a compound known for its central nervous depressive properties, which differs from traditional benzodiazepines. This invention highlights the potential of 2-methyl-thiazolo[4,5-c]quinoline and its pharmaceutically acceptable salt derivatives for therapeutic use.
Career Highlights
Throughout her career, Katalin has been affiliated with prominent pharmaceutical companies, including Egis Gyogyszergyar and BASF Aktiengesellschaft. Her work at these organizations has contributed significantly to her development as an inventor, allowing her to apply her innovative ideas in professional environments where research and development are paramount.
Collaborations
Katalin has had the privilege of working alongside esteemed colleagues such as Jozsef Knoll and Lujza E. Petocz. Their collaborations have not only enriched her research but also have combined their expertise to push forward the boundaries of pharmaceutical sciences.
Conclusion
Katalin Budai Nee Simonyi's work exemplifies the spirit of innovation and dedication in pharmaceutical research. Her patents witness her commitment to developing new therapeutic options that may improve patient care. As she continues to contribute to the scientific community, her achievements serve as an inspiration to aspiring inventors and researchers everywhere.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile